Progyny, Inc.

PGNY · Healthcare

$25.66

Markedsværdi: 1.97B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe Progyny, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

GlobeNewswire Inc.7. aug. 2026, 14.51

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

Progyny, Inc. (Nasdaq: PGNY), a women's health and family building solutions company, announced that CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston on August 11, 2026. The company recently reported record quarterly revenue, gross profit, and adjusted EBITDA for Q2 2026, with strong demand continuing for its women's health and family building solutions.